Development of a biomaterial associated with mesenchymal stem cells and keratinocytes for use as a skin substitute

Research Article investigating the characteristics of specially fabricated scaffolds aimed at use in wound healing applications, by Monica B Mathor, Bruna TS Santi, Dayane P Luco and Patricia Pranke (Brazil).

Go to the profile of Regenerative Medicine
Jun 10, 2016
0
0
Upvote 0 Comment

The use of scaffolds for regenerative medicine shows potential for supporting wound healing and regenerating damaged skin tissue, particularly for large burns and chronic wounds, where existing treatments often result in poor healing and significant scarring. In particular, a biocompatible and biodegradable scaffold at the lesion site would allow greater contact and interaction of cells at the injury site, and slow and steady degradation of the biomaterial could be important for regenerating damaged tissue.

This Research Article by Daniela Steffens, Monica B Mathor, Bruna TS Santi, Dayane P Luco and Patricia Pranke (Universidade Federal do Rio Grande do Sul, Instituto de Pesquisa com Células-tronco and Instituto de Pesquisas Energéticas e Nucleares, all Brazil) aimed to fabricate and characterize a cutaneous substitute combining mesenchymal stem cells, keratinocytes and an electrospun biomaterial comprised of poly-dl-lactic acid (PDLLA), hydrolyzed PDLLA (PDLLA/NaOH) or a PDLLA/NaOH scaffold linked to laminin protein, and see if the resulting scaffolds seem suitable for a wound healing application.

Steffens D, Mathor MB, Santi BTS, Luco DP, Pranke P. Development of a biomaterial associated with mesenchymal stem cells and keratinocytes for use as a skin substitute. Regen. Med. 10(8), 975–987 (2015).

Go to the profile of Regenerative Medicine

Regenerative Medicine

Journal, Future Science Group

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (www.future-science-group.com/journalprofile/regenerative-medicine/), where you can find the aims and scope of the journal and details of our international editorial board.

No comments yet.